1. Home
  2. HLF vs NUVB Comparison

HLF vs NUVB Comparison

Compare HLF & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Herbalife Ltd.

HLF

Herbalife Ltd.

HOLD

Current Price

$16.26

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$4.85

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLF
NUVB
Founded
1980
2018
Country
United States
United States
Employees
N/A
298
Industry
Other Pharmaceuticals
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
HLF
NUVB
Price
$16.26
$4.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
8
Target Price
$18.67
$11.38
AVG Volume (30 Days)
933.3K
2.9M
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.20
N/A
Revenue
$5,037,500,000.00
N/A
Revenue This Year
$4.97
$203.82
Revenue Next Year
$3.80
$58.18
P/E Ratio
$7.33
N/A
Revenue Growth
0.89
N/A
52 Week Low
$6.45
$1.57
52 Week High
$20.40
$9.75

Technical Indicators

Market Signals
Indicator
HLF
NUVB
Relative Strength Index (RSI) 53.38 55.16
Support Level $15.61 $4.06
Resistance Level $17.69 $5.55
Average True Range (ATR) 0.67 0.25
MACD 0.14 0.07
Stochastic Oscillator 66.58 67.14

Price Performance

Historical Comparison
HLF
NUVB

About HLF Herbalife Ltd.

Herbalife Ltd is a health and wellness company. It provides health and wellness products in 95 markets through a direct-selling business model. Its product categories include Weight Management, Targeted Nutrition, Energy, Sports and Fitness, Outer Nutrition, and Literature, Promotional, and Other. Weight Management generates the majority of revenue, with products such as meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Products are manufactured at facilities in Changsha and Suzhou, China; Lake Forest, California; and Winston-Salem, North Carolina, as well as by third-party providers. Revenues reflect sales to Members across North America, Latin America, EMEA, Asia Pacific, and China.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

Share on Social Networks: